Effect on Cerebral Vasospasm of Coil Embolization Followed by Microcatheter Intrathecal Urokinase Infusion Into the Cisterna Magna: A Prospective Randomized Study

Stroke

Volumn 34, Issue 11, 2003, Pages 2549-2554

  Hamada, Jun Ichiro ^a   Kai, Yutaka ^a   Morioka, Motohiro ^a   Yano, Shigetoshi ^a   Mizuno, Takamasa ^a   Hirano, Teruyuki ^a   Kazekawa, Kiyoshi ^b   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cerebral aneurysm; Cisterna magna; Embolization, therapeutic; Urokinase; Vasospasm

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CISTERNA MAGNA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; HYDROCEPHALUS; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; ANEURYSM, RUPTURED; BRAIN; CATHETERIZATION; CEREBRAL ANGIOGRAPHY; CISTERNA MAGNA; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; GLASGOW COMA SCALE; HUMANS; INFUSIONS, PARENTERAL; INJECTIONS, SPINAL; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VASOSPASM, INTRACRANIAL;

EID: 0242525542     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000094731.63690.FF     Document Type: Article

References (26)

1. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
2. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
3. Handa Y, Weir BKA, Nosko M, Mosewich R, Tsuji T, Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg. 1987;67:558-564.
4. Zabramski JM, Spetzler RF, Bonstelle C. Chronic cerebral vasospasm: effect of volume and timing of hemorrhage in a canine model. Neurosurgery. 1986;18:1-6.
5. Hamada JI, Mizuno T, Kai Y, Morioka M, Ushio Y. Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke. 2000;31:2141-2148.
6. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14-20.
7. Guglielmi G, Vinuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach, 2: preliminary clinical experience. J Neurosurg. 1991;75:8-14.
8. Sloan MA, Haley EC Jr, Kassell NF, Henry ML, Stewart SR, Beskin RR, Sevilla EA, Torner JC. Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology. 1989;39:1514-1518.
9. Jennet B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;1:480-484.
10. Inagawa T, Kamika K, Matsuda Y. Effect of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir (Wien). 1991;112: 28-36.
11. Taneda E. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg. 1982;57:622-628.
12. Nosko M, Weir BKA, Lunt A, Grace M, Allen P, Mielke B. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg. 1987;66:416-422.
13. Findlay JM, Kassell NF, Weir BKA, Haley EC Jr, Kongable G, Germanson T, Truskiwski L, Alves WM, Holness RO, Knuckey NW, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery. 1995;37:168-176.
14. Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1991;75:181-188.
15. Kajimoto Y, Ohta T, Kuroiwa T. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs. Neurosurgery. 1997;40:572-577.
16. Ohman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1991;75:197-201.
17. Seifert V. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: experimental and clinical data. Neurol Res. 1994;16:54-58.
18. Stolke D, Seifert V. Single intracistemal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery. 1992;30:877-881.
19. Usui M, Saito N, Hoya K, Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurg. 1994;34:235-245.
20. Zabramski JM, Spetzler RF, Lee S, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1991;75:189-196.
21. Brouweres PJ, Dippel DW, Vermeulen M, Lindsay KW. Hasan D, van Gijn J. Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke. 1993;24:809-814.
22. Fisher CM. Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin Neurosurg. 1975;22: 117-147.
23. Rabinstein AA, Pichelmann MA, Friedman JA, Piepgras DG, Nichols DA, McIver JI, Toussaint G, McClelland RL, Fulgham JR, Meyer FB, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg. 2003;98:319-325.
24. Simeone FA, Trepper P. Cerebral vasospasm with infarction. Stroke. 1972;3:449-455.
25. Kendall BE, Lee BCP, Claveria E. Computerized tomography and angiography in subarachnoid haemorrhage. Br J Radiol. 1976;49: 483-501.
26. Mizuno T, Hamada JI, Kai Y, Todaka T, Morioka M, Ushio Y. Intrathecal urokinase infusion via microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study. AJNR Am J Neuroradiol. 2003; 24:613-618.